HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

To learn more, please visit www.reprievetrial.org.

Disparities in HIV diagnosis rates were observed between Black and White individuals in the US from 2017 to 2021.

A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...

Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...